Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Mcmaster University
Headquarters: Hamilton, ON, Canada
Website: http://www.mcmaster.ca
Year Founded: 1887
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Apr 9, 2024
Discovery & Translation
AACR brings new modalities, new targets to glioblastoma
BioCentury identifies new CAR T cell designs, ADCs and other modalities, plus 37 preclinical targets for
BioCentury | Mar 25, 2022
Discovery & Translation
AACR22 tackles the CAR T solid tumor challenge
Dual-targeting CARs, new targets and bispecific adaptors among the top innovations
BioCentury | Feb 11, 2022
Distillery Therapeutics
BPIFB4 and downstream effector NOS3 as medulloblastoma targets
BioCentury | Jan 20, 2022
Management Tracks
GSK’s Thirsk joins Bavarian Nordic as COO
Plus Baroldi, Bastings join Ionis, and updates from Exscientia,
BioCentury | Dec 18, 2020
Product Development
2021 Predictions: a BioCentury survey
BioCentury’s SAB weighs in on what to expect in biotech in 2021 (See link at end to participate)
BioCentury | Sep 16, 2020
Management Tracks
HHS follows FDA, replacing political communications leader with career staff
Michael Caputo exits HHS after endorsing conspiracy theories
BioCentury | Aug 28, 2020
Finance
Turning to solid tumors, cell therapy play Triumvira earns syndicate’s $55M vote of confidence
A decision to stall a blood cancer program in favor of solid tumors helped drive investor interest
BioCentury | May 30, 2020
Translation in Brief
Empirica’s glioblastoma CAR T therapy in mice; plus tumor microbiomes by tumor type, Senhwa and more
BioCentury’s roundup of preclinical news
BioCentury | Apr 1, 2020
Distillery Therapeutics
Two glycopeptides for drug-resistant Gram-positive infections
Items per page:
1 - 10 of 98